Day One Biopharmaceuticals Inc. has appointed Michael Vasconcelles, M.D., as Head of Research and Development. Dr. Vasconcelles, with over 25 years of experience in oncology research and development, will lead the company's pipeline creation and execution. He joins the company at a pivotal time as it expands its focus on delivering transformative therapies for patients of all ages with life-threatening diseases.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.